Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07646652 · ClinicalTrials.gov registry record
Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease
A clinical trial, sponsored by Stanford University.
- Not yet
- Registry status
- 40
- Enrollment target
NCT07646652: Clinical Trial study, sponsored by Stanford University.
NCT07646652 is a clinical trial that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07646652 has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- 40 participants
- Enrollment target
Study Summary
The goal of the study is to assess if learning one's Lewy Body Dementia (LBD) biomarker test result impacts longitudinal psychosocial and behavioral responses and to identify factors that moderate and mediate these outcomes.
Primary Outcome
Distress related to biomarker disclosure will be assessed via the validated Impact of Event Scale-Revised (IES-R, a 22 item self-report measure). Scores range from 0 to 88; higher scores mean greater distress.
Interventions
- OTHER LBD Biomarker Education and Disclosure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-11 |
| Est. Completion | 2030-11 |
What is known before NCT07646652 opens enrollment
NCT07646652 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which LBD Biomarker Education and Disclosure is the first listed.
NCT07646652 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07646652 about?
NCT07646652 is a clinical study titled "Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease". The goal of the study is to assess if learning one's Lewy Body Dementia (LBD) biomarker test result impacts longitudinal psychosocial and behavioral responses and to identify factors that moderate and mediate these outcomes.
What is the current status of trial NCT07646652?
This trial is currently not yet recruiting. The enrollment target is 40 participants. The study started on 2026-11. Estimated completion is 2030-11.
What interventions are being tested in trial NCT07646652?
The interventions under investigation include: LBD Biomarker Education and Disclosure (OTHER).
Who is sponsoring clinical trial NCT07646652?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia